-
-
-
-
-
-
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $7 at Leerink Partners
-
-
-
-
-
-
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $36 at Canaccord Genuity
-
-
-
-
-
-
-
Rocket Pharmaceuticals (RCKT) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
Rocket Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
-
-
-
-
-
-
-
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial and Operational Results
-
-
-
-
-
-
-
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
-
-
-
-
-
-
-
Rocket Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
-
1,198,729 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

